NVAX (NVAX) Stock Price & Analysis
NVAX (NVAX) fell 1.16% to USD 10.22 as of September 8, 2026 at 05:02 UTC, according to Nexqual real-time market data.
NVAX last closed at USD 10.22; the session ranged USD 10.05–10.74 on volume of 5,125,027 shares. Market capitalization is —, with a 52-week range of USD 6.2–11.97 (NMS). Source: Nexqual, September 8, 2026 at 05:02 UTC.
Key Statistics (as of September 8, 2026 at 05:02 UTC)
| Price | USD 10.22 |
|---|---|
| Change | ▼ 1.16% (down) |
| Previous Close | USD 10.22 |
| Open | USD 10.22 |
| Day Range | USD 10.05 – 10.74 |
| 52-Week Range | USD 6.2 – 11.97 |
| Volume | 5,125,027 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (NVAX)
Nexqual's technical model rates NVAX "BUY" based on 5 bullish and 2 bearish signals across 128 daily candles, as of September 8, 2026 at 05:02 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 71.5 (overbought) |
| vs SMA50 | Above (USD 8.58) |
| MACD | 0.53 (positive) |
From NVAX's Latest SEC 10-K Filing (filed 2026-02-26)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| MRNA | Moderna, Inc. | USD 145.55 | ▼ 3.49% |
| INO | Inovio Pharmaceuticals, Inc. | USD 1.43 | ▲ 5.15% |
| BNTX | BioNTech SE | USD 103.76 | ▼ 0.05% |
| VXRT | Vaxart, Inc. | USD 0.5 | ▲ 2.04% |
| AZN | AstraZeneca PLC | USD 162.7 | ▲ 0.66% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 05:02 UTC. This page is informational and not investment advice.